New

ASPIRA-aXAY
with blue light protection

7.0 mm optic preloaded

ASPIRA-aXA
XL optic – vision without limits

ASPIRA-aXA

Pseudophakic reliability for you and your patients

The innovative XL optic of the ASPIRA-aXA combines the advantages of a 7.0 mm optic with the stability of the new cut-out haptic design. This posterior-chamber IOL an be conveniently implanted using small-incision technology while adhering to surgical routine.

Monofocal ASPIRA-aXA

Personal
Contact

TypeMonofocal 1-piece posterior chamber lens, foldable
Optic diameter 7.0 mm
Total diameter 11.0 mm
Material Glistening-free, hydrophilic acrylic, UV blocker
Optic features Aspherical anterior surface, aberration-free, 360° LEC barrier
Haptic design Cut-out haptics
Constants for IOL calculationPlease click here
XL diopter range ASPIRA-aXAPreloaded SAFELOADER®
10.0 to 30.0 D in 0.5 D steps

Compact Line
-10.0 to 9.0 D in 1.0 D steps
10.0 to 30.0 in 0.5 D steps

XL diopter range ASPIRA-aXAY YellowPreloaded SAFELOADER®
10.0 to 30.0 D in 0.5 D steps
eIFUASPIRA-aXA/-aXAY
SAFELOADER®
Injector systemPlease click here

Preloaded implantation system
SIMPLE. INTUITIVE. FAST.

SAFELOADER®

FOR AN UNTROUBLED VISUAL OUTCOME

PREVENT PHOTIC PHENOMENA

Pseudophakic dysphotopsia is the most important dissatisfier for patients after successful cataract surgery.

BENEFIT FROM A SMOOTH ADAPTION PHASE

PREVENT PERSISTENT DYSPHOTOPSIA

Bag-to-bag IOL exchange with the 7.0 mm Aspira-aXA showed complete resolution of dysphotopsia in almost all patients. An IOL exchange with a wide optic diameter IOL seems a promising surgical treatment for dysphotopsia.

Simulated beam guidance with a 6.0 mm optic

Simulated beam guidance with a 7.0 mm optic

The Aspira-aXA with the 7.0mm XL-optic reduces positive and negative dysphotopsia effectively.

A model

FOR THE DEVELOPMENT OF NEGATIVE DYSPHOTOPSIA

Numerous ray tracing analyses using standard IOLs show a non-illuminated region of the peripheral nasal retina. This “shadow” is caused by the reduced optic diameter and the central thickness of the artificial IOL compared to the natural lens.

Schematic drawing modified according to Holladay

2.5 mm pupil, 6.0 mm IOL

The retinal image is generated by light rays refracted by the IOL optic (areal A), as well as by light rays that hit the retinal periphery (area B) either directly or indirectly refracted by the IOL edge. The unilluminated gap between these two areas can lead to the perception of negative dysphotopsia.

THE PANORAMIC IOL

THINKING ONE STEP AHEAD

THE SOLUTION FOR VITREORETINAL SURGERY

AN INVESTMENT IN THE FUTURE

EXCELLENT INTRAOPERATIVE VIEW

Intraoperative fundus image* (1) Edge of the XL optic (2) Theoretical optic edge of a 6.0 mm IOL

* Courtesy of Univ.-Prof. Dr. M. Bolz, Linz

Dr. J. Schrecker, Glauchau, Germany
“We have been using Aspira-aXA for several years – especially in combination with vitreous surgery.
The particular advantage for me is the excellent stability of the IOL position and the vision, especially when using gas and oil tamponades. Even after almost two hundred implantations, no abnormalities, such as calcification or deposits of the hydrophilic material, occurred.“

Personal Statement, 2023

THE PANORAMIC IOL

EXPERTS RECOMMEND

Prof. W. Sekundo, Marburg
“The large ASPIRA-aXA optic has proven itself in phaco-vitrectomies because it allows an edge-free view into the outer retinal periphery.”
Personal Statement, 2018

Univ.-Prof. Dr. Matthias Bolz, MD, Linz
„The view into the periphery is not only important for standard funduscopy, but also for diagnostics, fluorescence angiography and above all for retinal surgery.”
Die ASPIRA-aXA aus Sicht eines Retinologen. Presentation DOC (Internationaler Kongress der Deutschen Ophthalmochirurgen), HumanOptics Booth Lecture, Nuremberg, 2018.

Y. Takamura, MD, PhD.
“The creation of a larger capsulorhexis with implantation of a 7.0 mm optic IOL contributed to a larger anterior capsule opening after cataract surgery in patients with DM [diabetes mellitus].”
Takamura, Y., et al. Large capsulorhexis with implantation of a 7,0 mm optic lens during cataract surgery in patients with diabetes mellitus. J Catract Refract Surg 2014; 40(11):1850-1856.

 

SAFE POSITIONING

STABLE REFRACTION

Dr. E. Becker, Oranienburg, Germany
“Aspira-aXA combines tilt-free fit, excellent A-constant fidelity with optical precision,
and its size makes it the number one monofocal IOL for eyes with a WTW greater than 12.0 mm and/or large pupils.”

Personal statement, 2023

CLINICALLY CONVINCING

Effective Reduction of Dysphotopsia

Excellent Stability

Highest Level of Patient Satisfaction

RefractionPostoperative CDVA stable over time:
After 1 month, median 0.00 logMAR; -0.10 bis 0.22
After 1.5 years, median 0.00 logMAR; -0.10 bis 0.10
Mean Tilt<5.5°, stable in the follow-up period
Mean Decentration<0.2 mm, stable in the follow-up period
Median Rotation1.8° one week postoperatively
No significant changes between surgery and 1.5-year follow-up

Choose

– AS DESIRED.

7.0 mm optic – preloaded

SAFELOADER®
SIMPLE. INTUITIVE. FAST.

The contactless preloaded implantation system offers a maximum of safety combined with its intuitive, easy handling.

Click here to see the application video
Reports from clinical application

The space-saving model

COMPACT LINE

For space-saving storage even when space is at a premium – ideal for use in the inpatient sector

Premium IOL ASPIRA-aXA

Your advantages of the premium IOL platform

Clinical performance

What do the experts say?

Dr. E. Becker/ M. Bonsemeyer, Oranienburg
“The ASPIRA-aXA with its enlarged XL optic represents a promising approach to minimize dysphotopsia.”
Piskula, M. Becker, E. (2018). Reduzierte pseudophake Dysphotopsien durch vergrößerte IOL-Optik. Presentation DGII 2018.

Prof. G. Duncker, Halle
“The patient response has been overwhelmingly positive.”
Personal Statement, 2018

 

Publications

Reports from clinical application

Pilger D., Bertelmann E., Brockmann T, et al.
Postoperative Lens Rotation of a 7.0 mm Optic IOL with Plate Haptics
Int J Ophthal Vision Res. 2021 Dec 07;5(1): 014-020.

Language: English

Borkenstein AF, Borkenstein EM
Efficacy of Large Optic Intraocular Lenses in Myopic Eyes with Posterior Segment Pathology
Ophthalmol Ther. 2021 Nov 27.doi: 10.1007/s40123-021-00433-3. Epub 2021 Nov 27.

Language: English

Schrecker J, Seitz B, Langenbucher A
[Performance of a new 7 mm intraocular lens with follow-up over 1.5 years]
Ophthalmologe. 2021 Oct 5.doi: 10.1007/s00347-021-01504-3. Online ahead of print.

Language: German

Bonsemeyer MK, Becker E, Liekfeld A
Dysphotopsiae and functional quality of vision after implantation of an intraocular lens with a 7.0 mm optic and plate haptic design
J Cataract Refract Surg. 2021 Jun 28.doi: 10.1097/j.jcrs.0000000000000735. Online ahead of print.

Language: English

Wendelstein J, Laubichler P, Fischinger I, et al.
Rotational Stability, Tilt and Decentration of a New IOl with a 7.0 mm Optic
Current Eye Research 2021 Jun;14
Click here for full report

Language: English

Borkenstein A. F., Borkenstein E. M.
Creating Hybrid Monovision with 7.0 mm XL Optic and High-Add AMD Intraocular Lenses (XL-MAGS) in a Patient with Retinitis Pigmentosa
Case Rep Ophthalmol 2019;10:304-311; doi: 10.1159/000503093

Click here for full report

Language: English

ASPIRA-aXA

Media reports

Interview with Becker, E. & Schrecker, J.
Improved Stability, Refractive Results With the Aspira-aXA IOL—A Novel IOL With Enlarged Optic Diameter
Cataract Refractive Surgery Today Europe 2020; 03:23

Click here for full article

Interview with Bolz, M.
aXA Good Question, Get a Good Answer
The Ophthalmologist 2019;10:59

Click here for full article

This post is also available in: German

OUR

CUSTOMER SERVICE

YOUR

QUESTIONS

Our experts support you with your questions at any time.

    *Mandatory field

    Meet HumanOptics in Germany at ESCRS Winter Meeting/DGII 2024!

    News
    News

    ESCRS Winter Meeting 2024 will take place in collaboration with the German Society for Cataract and Refractive Surgery (DGII) from the 15-18 February 2024 in Frankfurt, Germany. As a 100% German manufacturer of premium implants for eye surgery, the ESCRS Winter Meeting in Frankfurt is a real home game for us. Meet our team at […]